Discovery of quinazolin-4-one-based non-covalent inhibitors targeting the severe acute respiratory syndrome coronavirus 2 main protease (SARS-CoV-2 Mpro)
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Reference44 articles.
1. WHO, WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/(accessed date: 2022.December.14).
2. Hundreds of COVID trials could provide a deluge of new drugs;Ledford;Nature,2022
3. A comprehensive review of the global efforts on COVID-19 vaccine development;Li;ACS Cent. Sci.,2021
4. SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact;Lipsitch;Nat. Rev. Immunol.,2022
5. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression;Feikin;Lancet (London, England),2022
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Recent breakthroughs in synthetic small molecules targeting SARS-CoV-2 Mpro from 2022 to 2024;Bioorganic & Medicinal Chemistry;2025-10
2. Direct Antiviral Effects of Baicalin and Baicalein against SARS-COV-2: A Systematic Review;Current Nutrition & Food Science;2025-07
3. Synthesis of new selective agents with dual anti-inflammatory and SARS-CoV-2 Mpro inhibitory activity: Antipyrine-celecoxib hybrid analogues; COX-2, COVID-19 cytokine storm and replication inhibitory activities.;Bioorganic Chemistry;2025-06
4. Quinazoline, Imidazoline, and Azetidine Heterocycles via Oxidative Sulfonamidation of Camphene;Asian Journal of Organic Chemistry;2025-02-25
5. Structural Optimization of Quinazolin-4-one Derivatives as Novel SARS-CoV-2 Mpro Inhibitors by Molecular Simulation;Letters in Drug Design & Discovery;2024-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.7亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2025 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3